Lou, Z., X. Wang, C. Hu, W. Liu, and Y. Ji. “Combination of Anlotinib and Second-Line Chemotherapy As Surrogate to Reduce Immunosuppression in Patients With Advanced Non-Small Cell Lung Cancer”. Pakistan Journal of Medical Sciences, Vol. 40, no. 7, June 2024, doi:10.12669/pjms.40.7.9681.